- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Merge closes deal, raises cash
The acquisition of RIS Logic is done. Merge eFilm has closed the previously announced deal (SCAN 7/23/03) to acquire the privately held Ohio-based company, which specializes in the development of software for radiology information systems. The final
The acquisition of RIS Logic is done. Merge eFilm has closed the previously announced deal (SCAN 7/23/03) to acquire the privately held Ohio-based company, which specializes in the development of software for radiology information systems. The final price tag is $2.725 million in cash plus 772,000 shares of Merge Technologies common stock and the issuance of replacement employee stock options. RIS Logic will operate as a division of Merge eFilm and will maintain its Cleveland office location. Dan Quigg, former RIS Logic president and CEO, will serve as president of the RIS Logic division.
A private placement of 667,000 shares of common stock will more than offset the cost of the deal. The shares, sold to institutional investors at $12 apiece, have bolstered the company's coffers by slightly more than $8 million.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
